Oyster Point Pharma, Inc.'s (OYST) CEO Dr. Jeffrey Nau on Q1 2022 Results - Earnings Call Transcript

Oyster Point Pharma, Inc. (NASDAQ:NASDAQ:OYST) Q1 2022 Earnings Conference Call May 5, 2022, 4:30 PM ET Company Participants Arty Ahmed - Vice President, Investor Relations Dr.

Related Keywords

United States ,Ji Xing ,Jilin ,China ,Patrick Dolezal ,Chris Neyor ,Cory Jubinville ,Dan Lochner ,John Snisarenko ,Oyster Point Pharma Inc ,Company Participants ,Scripts National ,Ji Xing Pharmaceuticals ,Nasdaq ,Unitedhealth Group ,Oyster Point Pharma ,Conference Call May ,Jeffrey Nau ,First Quarter ,Party Ahmed ,Chief Executive Officer ,Chief Financial Officer ,Chief Commercial ,Chief Executive ,Oyster Point ,Chief Commercial Officer ,Express Scripts National Preferred ,Ken Cacciatore ,